Perspective Therapeutics (CATX) Shareholder's Equity (2011 - 2026)
Perspective Therapeutics (CATX) Shareholder's Equity (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 13.34 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - | 347.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 347.44 Mn |
| Dec 31, 2025 | 207.03 Mn |
| Sep 30, 2025 | 242.22 Mn |
| Jun 30, 2025 | 265.69 Mn |
| Mar 31, 2025 | 284.65 Mn |
| Dec 31, 2024 | 290.67 Mn |
| Sep 30, 2024 | 328.47 Mn |
| Jun 30, 2024 | 341.00 Mn |
| Mar 31, 2024 | 229.89 Mn |
| Dec 31, 2023 | 75.18 Mn |
| Sep 30, 2023 | 98.77 Mn |
| Jun 30, 2023 | 108.65 Mn |
| Mar 31, 2023 | 118.03 Mn |
| Dec 31, 2022 | 54.64 Mn |
| Sep 30, 2022 | 57.70 Mn |
| Jun 30, 2022 | 61.28 Mn |
| Mar 31, 2022 | 63.20 Mn |
| Dec 31, 2021 | 64.39 Mn |
| Sep 30, 2021 | 65.76 Mn |
| Jun 30, 2021 | 67.41 Mn |